申请人:Sumitomo Pharmaceuticals Co., Ltd.
公开号:US06576656B1
公开(公告)日:2003-06-10
An oxindole of Formula 1 or a prodrug thereof, or a pharmaceutically acceptable salt thereof is useful for growth hormone releaser:
wherein
R1, R2, R3 and R4 are independently hydrogen, optionally substituted alkyl etc;
R5 is optionally substituted aryl or optionally substituted heteroaryl;
Z is —O— or —NH—;
one of W1 and W2 is hydrogen, alkyl or —Y—CON(R10)R11;
the other of W1 and W2 is
n is 1, 2 or 3; m is 0, 1, 2 or 3;
Y is single bond or C1-C3 alkylene;
R6 and R7 are independently hydrogen, optionally substituted alkyl etc;
R8 and R9 are independently hydrogen, optionally substituted alkyl etc;
R10 and R11 are independently hydrogen, alkyl etc.
Formula 1的氧吲哚或其前药,或其药学上可接受的盐对生长激素释放剂有用:
其中
R1、R2、R3和R4独立地是氢、可选择地取代的烷基等;
R5是可选择地取代的芳基或可选择地取代的杂环芳基;
Z是—O—或—NH—;
W1和W2中的一个是氢、烷基或—Y—CON(R10)R11;
另一个是
n为1、2或3;m为0、1、2或3;
Y是单键或C1-C3烷基;
R6和R7独立地是氢、可选择地取代的烷基等;
R8和R9独立地是氢、可选择地取代的烷基等;
R10和R11独立地是氢、烷基等。